期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺鳞癌治疗进展 被引量：7

下载PDF
导出
摘要 1组织学类型与治疗历史回顾 20多年前，医生多认为肺鳞癌的主要治疗手段是局部治疗，对肺鳞癌患者大多不考虑化疗。后来研究发现，晚期肺鳞癌患者也可从化疗中获益。
作者 李峻岭 石远凯
机构地区 中国医学科学院北京协和医学院肿瘤医院肿瘤研究所
出处 《癌症进展》 2012年第2期120-123,共4页 Oncology Progress
关键词 肺鳞癌 化疗
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献17

  • 1Georgoulias V,Samonis G,Papadakis E. Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer:early results of a randomized trial[J].Lung Cancer,2001,(Suppl 4):47-51.
  • 2Hoang T,Suzanne D,Joan H S. Does Histology Predict Survival of Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Standard Platin-Based Chemotherapy? Retrospective Analysis of E1594[A].2009.PD6.4.1.
  • 3Scagliotti. G V,Parikh P,Pawel J v. Phase Ⅲ Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer[J].Journal of Clinical Oncology,2008,(21):3543-3551.doi:10.1200/JCO.2007.15.0375.
  • 4Johnson D H,Fehrenbacher L,Novotny W F. Randomized Phase Ⅱ Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic NonSmall-Cell Lung Cancer[J].Journal of Clinical Oncology,2004,(11):2184-2191.doi:10.1200/JCO.2004.11.022.
  • 5Sandler A,Gray R,Perry M C. Paclitaxel-Carboplatin Alone or with Bevacizumab for Non-Small-Cell Lung Cancer[J].New England Journal of Medicine,2006.2542-2550.doi:10.1056/NEJMoa061884.
  • 6Karp D D,Paz-Ares L G,Novello S. High activity of the anti-IGF-IR antibody CP-751,871 in combination with paclitaxel and carboplatin in squamous NSCLC[J].Journal of Clinical Oncology,2008,(Suppl 15):8015.
  • 7Karp D D,Novello S,Cardenal F. Continued high activity of figitumumab (CP-751,871) combination therapy in squamous lung cancer[J].Journal of Clinical Oncology,2009,(Suppl 15):8072.
  • 8Jassem J,Langer C J,Karp D D. Randomized,open label,phase Ⅲ trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC)[J].Journal of Clinical Oncology,2010,(Suppl 15):7500.
  • 9Yoo S H,Park Y S,Kim H R. Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung[J].Lung Cancer,2003,(02):195-202.
  • 10Koukourakis M I,Giatromanolaki A,Brekken R A. Enhanced expression of SPARC/osteonectin in the tumorassociated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients[J].Cancer Research,2003.5376-5380.

同被引文献73

引证文献7

二级引证文献33

癌症进展
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部